All In MedTech

FDA Clearance Tracker · P140008-S019

ORBERA Intragastric Balloon System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 2, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 2, 2020

Approved

Time to decision

177 days

Received Jun 8, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140008-S019
Device name
ORBERA Intragastric Balloon System
Applicant location
Marlboro, MA
Received
Jun 8, 2020
Decided
Dec 2, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P140008

Device type

Device class
Class III

Every decision under product code LTI

FDA's approval statement

As written in FDA's record.

Approval for the ORBERATM PAS (OPAS-001.0. The OPAS-001 is a prospective, open-label, single-arm study to evaluate the safety and effectiveness of ORBERA for weight reduction in obese adults 22 years and older with a BMI of 30-40 kg/m2. This is a 52-week study in which subjects will be treated during the first 26 weeks with ORBERA in conjunction with a behavioral modification program, followed by 26 weeks of behavioral modification program alone.A total of 284 subjects will be enrolled at 10 to 20 US sites to yield 255 subjects implanted with ORBERA (assuming a 10% screen failure rate). Based on an estimated attrition rate of 10% through week 26 and 20% through week 52, the expected number of evaluable subjects is 230 subjects at 26 weeks and 204 subjects at 52 weeks. A sample size of 255 implanted subjects will provide 80% power to test the hypothesis that the rate of device- and/or procedure-related serious adverse events (SAEs) is less than 15% at 26 weeks.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.